Pfizer Agrees to Pay $93 Million to Settle Lipitor Antitrust Lawsuit

Gelonghui February 15 | Pfizer, Inc. has agreed to pay $93 million to resolve antitrust claims brought by drug distributors. These distributors accused Pfizer of conspiring with Indian generic drug company Ranbaxy Laboratories to delay the sale of lower-priced generic versions of the cholesterol medication Lipitor. This agreement was disclosed in a document filed on February 14 in a U.S. court by multiple purchasers of Lipitor.